| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08.09.19 | Ipsen and Servier announce initial Phase II/III clinical data evaluating investigational liposomal irinotecan (ONIVYDE) as a second-line treatment for small cell lung cancer (SCLC) at the IASLC 2019 World Conference on Lung Cancer | 903 | Business Wire | 44% of patients achieved a response and nearly half (48%) maintained disease control at week 12 (efficacy as secondary endpoint)
Treatment emergent adverse events Grade 3 or higher were reported... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 1.631 |
| BAYER | 1.393 |
| NEL | 1.315 |
| TUI | 1.178 |
| PLUG POWER | 1.144 |
| NOVAVAX | 1.125 |
| SIEMENS ENERGY | 1.094 |
| MERCEDES-BENZ | 1.071 |
| PALANTIR TECHNOLOGIES | 757 |
| ALLIANZ | 716 |
| NVIDIA | 712 |
| RWE | 677 |
| DEUTSCHE BANK | 659 |
| BYD | 618 |
| DEUTSCHE LUFTHANSA | 573 |
| BASF | 571 |
| TESLA | 521 |
| VOLKSWAGEN | 508 |
| INFINEON | 492 |
| COMMERZBANK | 484 |
| AIXTRON SE | 469 |
| NORDEX | 464 |
| STANDARD LITHIUM | 450 |
| RENK GROUP | 447 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
